Pharmacogenetic, Clinical, Prescribing, and Demographic Predictors of Sertraline Pharmacokinetics. [PDF]
de la Cruz CG +8 more
europepmc +1 more source
Integrating PBPK Simulation and In Vitro Pharmacodynamics to Model Efavirenz-Associated Hepatic Oxidative Stress in Pregnancy. [PDF]
Costa B, Gouveia MJ, Vale N.
europepmc +1 more source
Clinical Relevance of the 516 G>T Polymorphism in CYP2B6 and Its Effects on Efavirenz Concentrations in Patients with HIV and Tuberculosis: A Meta-analysis. [PDF]
Villalpando-Solórzano A +5 more
europepmc +1 more source
The Effect of Artemisinin on the Pharmacokinetics of Cyclophosphamide and Its Metabolite in Mice and Its Potential Mechanisms. [PDF]
Wang H, Zhang W, Hu H, Wang S, Xie Y.
europepmc +1 more source
Associations of CYP2B6, CYP2C19, and CYP2D6 isoforms and phenoconversion with sertraline pharmacokinetics. [PDF]
Tapia-Alzuguren B +3 more
europepmc +1 more source
Population-Scale Pharmacogenomic Profiling in the Western Balkan Populations. [PDF]
Ćurić I +20 more
europepmc +1 more source
Determinants of HIV-1 virologic suppression in HIV-associated tuberculosis in Brazil. [PDF]
Ridolfi F +22 more
europepmc +1 more source
Inhibition of cytochrome P450 activities by juglone in human and rat liver microsomes: kinetic characterization and implications for natural product-drug interaction assessment. [PDF]
Zhao L +7 more
europepmc +1 more source
Trastuzumab emtansine silences Cyp2B6.
Mechanism of action for antibody drug conjugates has not yet been completely elucidated. We demonstrate here through the use of RNA-sequencing specific silencing of Cyp2B6 by trastuzumab emtansine, T-DM1.
openaire +3 more sources

